Commitment COM-183
Post-approval commitment for PMDA-2022-0083. Category: Risk Management. Priority: high.
Commitment ID
COM-183
Application
Authority
Pharmaceuticals and Medical Devices Agency
Category
Risk Management
Priority
high
Status
In Progress
Due Date
2025-02-04
Completed At
—
Owner
Aisha Okonkwo
Created
2022-10-24
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.